Search Results - "tyrosine"

Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors by Delong Liu, Karen Seiter, Nasir Ahmed, Samir Patel, Xuan Huang

Connect to this object online.

Role of Soluble FMS-Like Tyrosine Kinase (SFLT-1) /Placental Growth Factor (Plgf) Ratio as Prognostic Marker for Cases of Preeclampsia by Gasser M Elbishry, Ihab F Serag Eldin, Ahmed A ElShahawy, Gihan E Hawwary, Ahmed M Riad

Connect to this object online.

Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology by A. V. Tarasiuk, Y. V. Mezentsev, O. V. Gnedenko, P. Yu. Povarnina, A. S. Ivanov

Connect to this object online.

Correction to: Fischer et al., Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance

Connect to this object online.

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary by Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Zsolt Abonyi-Toth, Judit Demeter

Connect to this object online.

Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies by Adel S. El-Azab, Abdullah Al-Dhfyan, Alaa A.-M, Laila A. Abou-Zeid, Hamad M. Alkahtani, Abdulrahman M. Al-Obaid, Manal A. Al-Gendy

Connect to this object online.

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia by Mahmoud Fathy Hassan, Nancy Mohamed Ali Rund, Ahmed Husseiny Salama

Connect to this object online.

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma by Yue Chen, Yue Chen, Yutao Wang, Yutao Wang, Jin Lei, Bowen Chen, Bowen Chen, Xinfeng Zhang, Xinfeng Zhang, Liangzheng Chang, Zhangli Hu, Yun Wang, Yinying Lu, Yinying Lu, Yinying Lu

Connect to this object online.

Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT‐1: Influence on 18F‐FDG PET Uptake by Vijaya L. Damaraju, Maral Aminpour, Michelle Kuzma, Philip Winter, Jordane Preto, Jack Tuszynski, Alexander B.J. McEwan, Michael B. Sawyer

Connect to this object online.

Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials by Wu L, Zhang Z, Yao H, Liu K, Wen Y, Xiong L

Connect to this object online.

Tissues response and bone-forming capacity of zinc oxide-eugenol sealer following the addition of nanohydroxyapatite-tyrosine amino acid: An in vivo animal study by Rasha M. Al-Shamaa, Raghad A. Al-Askary

Connect to this object online.

An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma by Sorah Yoon, Xiwei Wu, Brian Armstrong, Nagy Habib, John J. Rossi

Connect to this object online.

Benzofuran-appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies by Malose J. Mphahlele, Marole M. Maluleka, Abimbola Aro, Lyndy J. McGaw, Yee Siew Choong

Connect to this object online.

PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, relieves airway hyperresponsiveness, mucus hypersecretion and inflammation in a murine asthma model by Wei Li, Lu Xue, Changsi Peng, Ping Zhao, Yongbo Peng, Weiwei Chen, Wenyi Wang, Jinhua Shen

Connect to this object online.

PENAMBATAN MOLEKUL SENYAWA AKTIF CURCUMA XANTHORRHIZA ROXB KANDIDAT ANTI KANKER KOLOREKTAL TERHADAP RESEPTOR LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE by Nasywa Oryza Sativa, Adelia Ofira Putri, Zaskiya Natasya, Rana Atikah Rislia, Lutfiyana Ulfa, Miska Aulia Karima, Selvi Balqis, Anjar Hermadi Saputro, Winni Nur Auli

Connect to this object online.

Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP) by Rhiannon N. Hardwick, Marina Snellings, Brian C. Ferslew, Yang Lu, Kim L.R. Browuer

Connect to this object online.

A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia by Alicia Martín Roldán, María Del Mar Sánchez Suárez, Carolina Alarcón-Payer, Alberto Jiménez Morales, José Manuel Puerta Puerta

Connect to this object online.

Orbital involvement by NUT midline carcinoma: new presentation and encouraging outcome managed by radiotherapy combined with tyrosine kinase inhibitor: a case report by Peiwei Chai, Chuandi Zhou, Renbing Jia, Yefei Wang

Connect to this object online.

Differences Ratio Level Soluble FMS-Like Tyrosine Kinase-1 and Placental Growth Factor Early And Late Onset on Preeclampsia and Normal Pregnancy by Ria Andina, Yanwirasti Yanwirasti, Defrin Defrin

Connect to this object online.

Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods by Rezvan Rezaee Nasab, Mahboubeh Mansourian, Farshid Hassanzadeh, Mohsen Shahlaei

Connect to this object online.